Fibrosis progression
Showing 1 - 25 of >10,000
Atrial Fibrillation, Obstructive Sleep Apnea Trial in New Orleans (Delayed enhancement magnetic resonance imaging (DE-MRI))
Recruiting
- Atrial Fibrillation
- Obstructive Sleep Apnea
- Delayed enhancement magnetic resonance imaging (DE-MRI)
-
New Orleans, LouisianaTulane University Medical Center
Nov 21, 2022
Chronic Hepatitis B:Multicenter Retrospective Cohort Study
Recruiting
- Hepatitis B, Chronic
-
Amsterdam, Netherlands
- +2 more
Jan 23, 2023
Progressive Fibrosing Interstitial Lung Disease
Completed
- Lung Diseases, Interstitial
-
Ridgefield, ConnecticutBoehringer Ingelheim Pharmaceuticals, Inc.
May 16, 2023
Pulmonary Fibrosis Trial in Worldwide (Electronic nose)
Recruiting
- Pulmonary Fibrosis
- Electronic nose
-
Lyon, France
- +3 more
Aug 5, 2022
Decompensated Cirrhosis Trial in Shanghai (Low-dose of Rifaximin, Conventional dose of Rifaximin)
Recruiting
- Decompensated Cirrhosis
- Low-dose of Rifaximin
- Conventional dose of Rifaximin
-
Shanghai, ChinaShanghai East Hospital
May 16, 2023
Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
- Idiopathic Pulmonary Fibrosis
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Nov 1, 2021
Liver Cirrhoses Trial in Hvidovre (Placebo oral tablet, Atorvastatin 10mg)
Terminated
- Liver Cirrhoses
- Placebo oral tablet
- Atorvastatin 10mg
-
Hvidovre, Danmark, DenmarkGastro Unit, medical Division, University Hospital Hvidovre
Jan 11, 2023
Chronic Hepatitis b, NAFLD, Cirrhosis Trial in Hong Kong (Empagliflozin 10 MG, Placebo pills)
Recruiting
- Chronic Hepatitis b
- +5 more
- Empagliflozin 10 MG
- Placebo pills
-
Hong Kong, Hong Kong, China, Hong KongThe University of Hong Kong/Queen Mary Hospital
May 31, 2022
Alcoholic Liver Disease, Liver Cirrhosis, Alcoholic, Probiotics Trial in Odense (Profermin Plus, FSMP, probiotics, Fresubin,
Active, not recruiting
- Alcoholic Liver Disease
- +3 more
- Profermin Plus, FSMP, probiotics
- Fresubin, dietary supplement
-
Odense, Fyn, Denmark
- +1 more
Aug 18, 2022
Gut Permeability and Bariatric-metabolic Surgery
Recruiting
- NASH - Nonalcoholic Steatohepatitis
- +2 more
-
Vienna, AustriaMedical University of Vienna
Feb 16, 2022
The Visceral Adiposity Measurement and Observation Study
Recruiting
- HIV
- +18 more
- Diagnostic Test
- HIV Anti-retroviral Background Therapy
-
Los Angeles, California
- +5 more
Sep 21, 2022
CoV2 SARS Pneumonia Trial in Le Plessis-Robinson, Paris, Villejuif (CHEST CT SCAN)
Recruiting
- CoV2 SARS Pneumonia
- CHEST CT SCAN
-
Le Plessis-Robinson, France
- +2 more
Aug 6, 2021
Inflammation and Airway Disease in Infants and Cystic Fibrosis
Active, not recruiting
- Cystic Fibrosis
-
New Haven, ConnecticutCystic Fibrosis Clinic, Yale New Haven Hospital
Apr 19, 2021
Progressive Idiopathic Pulmonary Fibrosis Trial in France (pirfenidone and nintedanib, pirfenidone or nintedanib)
Recruiting
- Progressive Idiopathic Pulmonary Fibrosis
- pirfenidone and nintedanib
- pirfenidone or nintedanib
-
Angers, France
- +15 more
Jan 20, 2022
Kidney Transplantation, Kidney Failure Trial in Zagreb (Mycophenolate mofetil)
Completed
- Kidney Transplantation
- Kidney Failure
- Mycophenolate mofetil
-
Zagreb, HR, CroatiaClinical Hospital Merkur
Oct 18, 2021
Liver Cirrhosis Trial in Aarhus (Faecal microbiota transplantation, Placebo)
Recruiting
- Liver Cirrhosis
- Faecal microbiota transplantation
- Placebo
-
Aarhus, DenmarkDepartment of Hepatology and Gastroenterology, Aarhus University
Nov 3, 2021
Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI
Recruiting
- Cystic Fibrosis
- Hyperpolarized Xenon
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jun 16, 2021
Cirrhosis, Portal Hypertension Trial in Shanghai (Spironolactone and carvedilol, Carvedilol)
Completed
- Cirrhosis
- Portal Hypertension
- Spironolactone and carvedilol
- Carvedilol
-
Shanghai, Shanghai, ChinaShanghai Tongji Hospital, Tongji University
Aug 21, 2020
NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis Trial (Biological specimens, Additional visit)
Not yet recruiting
- NAFLD
- +4 more
- Biological specimens
- Additional visit
- (no location specified)
Jun 7, 2021
Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Sarcoidosis Trial in Charlottesville (Interstitial Lung Disease)
Enrolling by invitation
- Interstitial Lung Disease
- +5 more
- Interstitial Lung Disease
-
Charlottesville, VirginiaUniversity of Virginia Health System
May 20, 2021
Early Lung Physiology, Viral Infections and Microbiota on
Recruiting
- Confirmed Diagnosis of Cystic Fibrosis
- no intervention
-
Bern, SwitzerlandUniversity Children's Hospital Bern
Nov 3, 2020
From Acute to Chronic Pancreatitis
Recruiting
- Pancreatitis
- +5 more
- Diagnostic imaging
-
Hvidovre, Capital Region Denmark, Denmark
- +2 more
Apr 7, 2020
Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung
Not yet recruiting
- Progressive Fibrosing Interstitial Lung Disease
- Hyperpolarized xenon-129 MRI
-
Aarhus, DenmarkAarhus University, Department of Clinical Medicine, MR Research
Jun 19, 2023
HIV, Fatty Liver Disease Trial in Madrid (Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day, Tenofovir disoproxil
Recruiting
- HIV Infections
- Fatty Liver Disease
- Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day
- +2 more
-
Madrid, Spain
- +3 more
Jun 13, 2023